ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,156Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 890

$895K Total Retail Price of All Prescriptions

Rank: 68 out of 890

478 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

26% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 656 405 S3 1 3
SIMVASTATIN 519 348 2 5
LISINOPRIL 465 291 3 4
LEVOTHYROXINE SODIUM 435 311 4 2
ZOLPIDEM TARTRATE 383 247 5 19
AMLODIPINE BESYLATE 373 326 6 1
OMEPRAZOLE 351 259 7 8
METFORMIN HCL 322 248 8 6
ATORVASTATIN CALCIUM 288 203 9 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 278 199 10 21
NEXIUM 272 153 11 14
GABAPENTIN 270 139 12 12
FUROSEMIDE 242 190 13 7
ATENOLOL 222 158 14 23
TERAZOSIN HCL 205 163 15 142
LOSARTAN POTASSIUM 203 171 16 29
GLIMEPIRIDE 202 157 17 27
MELOXICAM 173 112 18 18
CLOPIDOGREL 169 132 19 28
POTASSIUM CHLORIDE 168 156 20 11
PRAVASTATIN SODIUM 165 140 21 10
ADVAIR DISKUS 164 99 22 52
CARVEDILOL 163 125 23 22
HYDROCHLOROTHIAZIDE 161 111 24 9
METOPROLOL TARTRATE 158 91 25 15
TRAMADOL HCL 157 112 26 16
CLONIDINE HCL 145 122 27 35
WARFARIN SODIUM 145 69 27 24
CRESTOR 144 81 29 25
ALENDRONATE SODIUM 141 113 30 38
LYRICA 136 59 31 71
AMITRIPTYLINE HCL 132 81 R 32 43
METOPROLOL SUCCINATE 129 116 33 17
PLAVIX 124 103 34 42
FENOFIBRATE 123 102 35 74
METHYLPREDNISOLONE 123 82 35 109
FLUOXETINE HCL 119 69 37 63
DIOVAN 116 104 38 33
LANTUS 113 52 39 50
LOVAZA 112 60 40 120
TAMSULOSIN HCL 101 89 41 32
ESCITALOPRAM OXALATE 98 58 42 51
ALLOPURINOL 98 85 42 31
NIFEDIPINE ER 96 73 44 75
SERTRALINE HCL 89 76 45 26
INSULIN SYRINGE 88 64 46 99
AMLODIPINE BESYLATE-BENAZEPRIL 87 65 47 41
LIPITOR 85 61 48 77
LEVOFLOXACIN 84 63 49 107
MECLIZINE HCL 84 70 49 97
FLURBIPROFEN 83 62 51 384
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 56 51 76
PAROXETINE HCL 81 54 53 68
ENALAPRIL MALEATE 79 62 54 56
OXYBUTYNIN CHLORIDE 77 49 55 139
JANUVIA 76 65 56 59
TRICOR 75 26 57 98
CIPROFLOXACIN HCL 75 48 57 58
LOVASTATIN 73 61 59 46
RANITIDINE HCL 72 38 60 49
LANTUS SOLOSTAR 68 47 61 102
TRAMADOL HCL-ACETAMINOPHEN 67 42 62 117
DIGOXIN 67 50 62 65
TRAZODONE HCL 65 29 64 40
DIOVAN HCT 65 40 64 48
ROPINIROLE HCL 64 47 66 93
PRIMIDONE 64 33 66 289
CITALOPRAM HBR 63 30 68 20
FINASTERIDE 62 62 69 108
NAMENDA 62 52 69 36
TRIAMCINOLONE ACETONIDE 61 39 71 160
LANSOPRAZOLE 61 35 71 171
DONEPEZIL HCL 60 60 73 30
AZITHROMYCIN 59 34 74 37
GLYBURIDE-METFORMIN HCL 58 58 R 75 115
PANTOPRAZOLE SODIUM 58 20 75 34
SINGULAIR 57 31 77 79
GLIPIZIDE 57 50 77 62
LOSARTAN-HYDROCHLOROTHIAZIDE 56 40 79 57
CYMBALTA 56 15 79 45
BENAZEPRIL HCL 56 56 79 44
ISOSORBIDE MONONITRATE ER 55 47 82 60
PROAIR HFA 55 31 82 55
NYSTATIN-TRIAMCINOLONE 54 34 84 277
FLUTICASONE PROPIONATE 54 37 84 39
BENZTROPINE MESYLATE 52 14 R 86 196
PEN NEEDLE 51 37 87 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.